Navigation Links
Physician Staffing Trends and Hospitalist Jobs Fuel Growth at Locum Leaders
Date:1/5/2009

ALPHARETTA, Ga., Jan. 5 /PRNewswire/ -- Locum Leaders (http://www.locumleaders.com), a leading physician and nurse recruiting firm specializing in temporary medical staffing, known as locum tenens, is projecting rapid growth in 2009. The company's positive outlook is fueled by increased industry demand in key physician specialties and the company's strategic investments in technology and service.

"The economy notwithstanding, we predict strong quarterly growth in our business, especially in the areas of hospital medicine (patient care delivered by hospital-based physicians) and anesthesiology," said Will Drescher, Locum Leaders CEO. "Demand for hospitalists is surging and we are positioned as a national leader in the placement of locum tenens hospitalist physicians."

Locum tenens is a Latin phrase meaning "to substitute or take the place of." Locum Leaders contracts with healthcare facilities that have temporary staffing needs, such as vacation openings, and then recruits and places qualified physicians and CRNAs (Certified Registered Nurse Anesthetists) to fill those needs -- often by temporarily relocating the healthcare provider.

Locum tenens is the fastest-growing segment of the U.S. medical staffing industry, according to analysts. "Physician turnover at hospitals and doctor and CRNA shortages are catalysts for our business," said Drescher.

Locum Leaders was launched in 2008 and its leadership team is drawn from industry veterans with a track record of success. CEO Drescher was previously a Partner and Vice President at Locum Tenens.com. Investment for Locum Leaders comes from W3, LLC of Alpharetta, GA, whose principals were partners at B2B Workforce, a leading IT recruiting company acquired in 2007.

Although a young company, Locum Leaders has invested heavily in client services and technology that Drescher
'/>"/>

SOURCE Locum Leaders
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Increased distance to physician associated with thicker skin cancer at diagnosis
2. Broad-based group of physicians calls for improvement in stroke treatment
3. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
4. Psychiatrists are the least religious of all physicians
5. Physician Skin Care Specialist Says Proposed New Rules for Sunscreen Products Will Better Protect the Public
6. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
7. Texas Largest Physician Carrier Announces 5th Successive Rate Cut on Anniversary of Lawsuit Reform
8. Maimonides Expands Circulation of Physicians Practice Journal to Staten Island Doctors
9. Scientists, physicians present latest findings in personalized cancer treatment and prevention
10. NNN Healthcare/Office REIT Acquires St. Mary Physicians Center in Long Beach, California
11. Physician Team at Northwestern Memorial Performs Rare Oral Gallbladder Removal
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Today at the State Capitol, ... with the California Healthcare Institute (CHI) and the ... Assembly resolution recognizing Feb. 28, 2015 as Rare ... caring for millions of Californians living with nearly ... policy research organization, representing leading California academic institutions, ...
(Date:3/2/2015)... 02, 2015 Surgeons at the ... Allegheny Health Network, are exploring an innovative use ... Visual Info Zonal Reminder (VIZR), to assist in the ... Google Glass is a wearable technology with an optical ... format. Wearers communicate with the Internet via natural language ...
(Date:3/2/2015)... Ticket Down is a reputable source ... . This popular site has reduced all ticket prices ... for added savings. , Parrotheads in the Los Angeles ... headlining at the Hollywood Bowl for the first time ... October 22nd and it will be in conjunction with ...
(Date:3/2/2015)... Doctors in Novara, Italy have found that ... outcomes for people with mesothelioma than other clinical factors. ... new study on the Surviving Mesothelioma website. , ... Piedmont followed the cases of 172 mesothelioma patients ... fluid. , “Persistent lung expansion after pleural talc ...
(Date:3/2/2015)... Burns Engineering's Lab-to-Lab Calibration Service ... Standard Platinum Resistance Thermometers (SSPRTs) and industrial Resistance ... less . . . guaranteed. Their ... Code 200706-0), ISO 9001 and 17025 Certified and ... -196°C to 500°C, both ITS-90 and Callendar-van Dusen ...
Breaking Medicine News(10 mins):Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 2Health News:California Healthcare Institute Spotlights Impact of Rare Diseases with Assemblymember Katcho Achadjian 3Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2
... Study may lead to new treatments for PTSD, researchers ... with stress-related psychiatric conditions have faulty circuitry in the ... new study suggests. , For the study, researchers presented ... patients, those with major depression and those with other ...
... and dental office,staff have realized the benefits of ... taken advantage of electronic predeterminations.,These electronic transactions may ... benefit information while the patient is still,in the ... "Paper submissions typically take 10 to 14 business ...
... starting school suffer from sleep disturbances and these may ... current edition of Deutsches rzteblatt International ( ... and adolescent psychiatrist Gerd Lehmkuhl and his colleagues present ... , The authors have as yet interviewed 1388 children ...
... , Montreal, December 3rd, 2008 A Canadian and ... from the Research Institute at the Montreal Children,s Hospital of ... Canadian Institutes of Health Research (CIHR) and the Foundation Fighting ... research project to develop innovative gene therapies for a number ...
... CINCINNATI A genetic malfunction that causes DNA instability ... put them at high risk for squamous cell carcinomas ... posted online ahead of print by Oncogene . ... report the breakdown of a cell signaling pathway for ...
... HLTH Corporation (Nasdaq: HLTH ) announced today ... 80,000,000 shares of its common stock at a price of $8.80 ... on November 25, 2008. As previously announced, HLTH exercised its ... extending the tender offer and has accepted for purchase 83,699,922 shares, ...
Cached Medicine News:Health News:Memory Formation Different in Those With Stress-Related Psychiatric Disorders 2Health News:Electronic Submission for Dental Predeterminations May Increase Efficiency, Patient Satisfaction 2Health News:CA$2.4 million toward gene therapy for human degenerative retinal diseases 2Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 2Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 3Health News:Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer 4Health News:HLTH Corporation Announces Final Results of Its Tender Offer 2Health News:HLTH Corporation Announces Final Results of Its Tender Offer 3
(Date:3/2/2015)... 2, 2015   Emerson Ecologics, LLC ... supplements, prescription products and natural health and ... with Anabolic Laboratories, a leading manufacturer of ... new partnership will allow Anabolic Laboratories to ... practitioner segments and provide customers with added ...
(Date:3/2/2015)... Conn., March 2, 2015  Compass Diversified Holdings (NYSE: ... "Company"), an owner of leading middle market businesses, announced ... twelve months ended December 31, 2014. Fourth ... for Distribution and Reinvestment ("CAD" or "Cash Flow") of ... $58.0 million for the full year 2014;  , ...
(Date:3/2/2015)... CUPERTINO, Calif. , March 2, 2015 /PRNewswire/ ... announced its Epigenomic Regulator Program, and the successful ... the program,s lead product candidate DUR-928.  DUR-928 is ... may have broad applicability in metabolic diseases such ... steatohepatitis (NASH), and in acute organ injuries such ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5
... Dec. 4 Long-term data published in,EuroIntervention showed ... (MVA),after repair with the MitraClip(R) system to correct ... mitral stenosis. Additionally,with two years of follow-up, none ... surgery for mitral stenosis. At 12 months no,important ...
... newly diagnosed patients with a life-threatening type of leukemia to be ... , - Exjade results at ASH to show benefits ... damage key organs , , - ... to report on optimal post-surgery treatment strategy, Femara vs. tamoxifen , ...
Cached Medicine Technology:Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22
... Medical® clear, all-silicone Foley catheters eliminate ... other Foley catheter designs. As an ... for creating a safe, dependable Foley ... Medical's all-silicone catheters will not leach ...
... Used for stone manipulation ... tract. Enhanced wire strength permits ... ureter more readily than standard ... facilitates easy, ergonomic one-handed operation. ...
... for soft-tissue repair, including, ... paravaginal repairs, such as ... Surgisis® ES is designed ... for intraoperative applications. Supplied ...
... Used to prevent ... allow renal drainage after ... in peel-open packages. Intended ... Periodic evaluation is advised; ...
Medicine Products: